@article {Patrikar2020.06.27.20141424, author = {SR Patrikar and A Kotwal and VK Bhatti and A Banerjee and K Chatterjee and R Kunte and M Tambe}, title = {Incubation Period and Reproduction Number for novel coronavirus (COVID-19) infections in India}, elocation-id = {2020.06.27.20141424}, year = {2020}, doi = {10.1101/2020.06.27.20141424}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Novel coronavirus (COVID-19) rapidly spread from China to other parts of the world. Knowledge of incubation period and reproduction number is important in controlling any epidemic. The distribution of these parameters helps estimate the epidemic size and transmission potential of the disease. We estimated incubation period and reproduction number of COVID-19 for India utilizing data reported by Ministry of Health and Family Welfare (MoHFW), Government of India (GOI) and data in public domain. The mean incubation period seems to be larger at 6.93 (SD={\textpm}5.87, 95\% CI: 6.11-7.75). and 95th percentile estimate for best fit normal distribution is 17.8 days. Weibull distribution, the best fit for the reproduction number estimated pre lockdown reproduction number as 2.6 (95\% CI=2.34 - 2.86) and post lockdown reduced to 1.57 (95\% CI=1.3 {\textendash} 1.84) implying effectiveness of the epidemic response strategies. The herd immunity is estimated between 36-61\% for R0 of 1.57 and 2.6 respectively.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The manuscript is based on secondary data available in public domainAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe analysis is based on publicly available data https://www.mohfw.gov.in/ https://www.covid19india.org/}, URL = {https://www.medrxiv.org/content/early/2020/06/29/2020.06.27.20141424}, eprint = {https://www.medrxiv.org/content/early/2020/06/29/2020.06.27.20141424.full.pdf}, journal = {medRxiv} }